Results for tag: "Exparel"

Exparel is a long-acting, non-opioid analgesic used to provide post-surgical pain relief. It is a liposome-encapsulated formulation of bupivacaine, a local anesthetic, and is administered as a single-dose infiltration into the surgical site. Exparel is designed to provide up to 72 hours of pain relief, allowing patients to reduce or eliminate the need for opioid-based pain medications. Exparel is used in a variety of surgical procedures, including orthopedic, gynecologic, and general surgeries. It is also used in dental procedures, such as wisdom tooth extraction. Exparel is approved for use in adults and children over the age of two. Exparel is a part of the larger analgesic market, which includes both opioid and non-opioid pain medications. Non-opioid analgesics, such as Exparel, are increasingly being used as an alternative to opioids due to their lower risk of addiction and side effects. Companies in the Exparel market include Pacira Pharmaceuticals, Inc., which manufactures and markets the drug, as well as distributors such as McKesson Corporation and AmerisourceBergen Corporation. Show Less Read more